Cargando…

Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica

Patients suffering from neuro-inflammatory diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) remain vulnerable to COVID-19. We investigated the risk of COVID-19 in MS and NMOSD patients over time, considering the impact of disease-modifying treatments (DMTs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisler, Jennifer Jessica, Disanto, Giulio, Sacco, Rosaria, Zecca, Chiara, Gobbi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488002/ https://www.ncbi.nlm.nih.gov/pubmed/37685618 http://dx.doi.org/10.3390/jcm12175551

Ejemplares similares

Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
por: Scotti, Barbara, et al.
Publicado: (2018)

Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
por: Zecca, Chiara, et al.
Publicado: (2019)

Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
por: Disanto, Giulio, et al.
Publicado: (2022)

Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
por: Zecca, Chiara, et al.
Publicado: (2020)

Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
por: Riccitelli, Gianna C., et al.
Publicado: (2021)

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
por: Zecca, Chiara, et al.
Publicado: (2017)

Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis
por: Ostini, Camilla, et al.
Publicado: (2021)

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
por: Caporro, Matteo, et al.
Publicado: (2014)

Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus
por: Shaygannejad, Vahid, et al.
Publicado: (2020)

Demyelinating syndrome in systemic sclerosis and neuromyelitis optica
por: Deeb, Khaled, et al.
Publicado: (2019)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping
por: Sparasci, Davide, et al.
Publicado: (2022)

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
por: Sormani, Maria P., et al.
Publicado: (2021)

Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)
por: Rodney, Cady, et al.
Publicado: (2020)

Moyamoya disease in a patient with neuromyelitis optica
por: Chan, Nathan H., et al.
Publicado: (2014)

A Case of Neuromyelitis Optica (Devics' Disease)
por: Singh, Amarjit
Publicado: (1944)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Profile of neuromyelitis optica and spectrum disorders in an Indian cohort
por: Koudriavtseva, Tatiana, et al.
Publicado: (2015)

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases
por: Yokote, Hiroaki, et al.
Publicado: (2016)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
por: Matthews, Lucy, et al.
Publicado: (2015)

Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine
por: Fujikawa, Priscilla, et al.
Publicado: (2021)

Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update
por: Noval, Susana, et al.
Publicado: (2011)

Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica
por: Etemadifar, Masoud, et al.
Publicado: (2014)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016)

Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica
por: Shin, Joon Sung, et al.
Publicado: (2019)

The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
por: Moayednia, Milad, et al.
Publicado: (2021)

Neuromyelitis Optica in a Young Woman With Tuberous Sclerosis: Is There an Association?
por: Elkhooly, Mahmoud, et al.
Publicado: (2022)

The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Cho, Eun Bin, et al.
Publicado: (2023)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Neuromyelitis optica associated with systemic autoimmune diseases in children
por: Russo, RA, et al.
Publicado: (2008)

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

Neuromyelitis optica spectrum disorders without and with autoimmune diseases
por: Zhang, Bingjun, et al.
Publicado: (2014)

Neuromyelitis Optica (Devic's Disease). A Case Report
por: Mascati, Naumann T.
Publicado: (1949)

Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report
por: de Ruijter, Naomi S., et al.
Publicado: (2020)

Neuromyelitis optica with rapid respiratory failure: a case report
por: Otake, Kosuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ltj1cullm7enmafvan8i3fupr